Press release
Keratoconus Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, Clinical Trials by DelveInsight | CooperVision, Optik Seis, SAFILENS S.R.L, Novartis, CIBA VISION, Menicon, Bausch & Lomb
"Keratoconus Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Keratoconus Market.
The Keratoconus Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Keratoconus Pipeline Report:
*
Companies across the globe are diligently working toward developing novel Keratoconus treatment therapies with a considerable amount of success over the years.
*
Keratoconus companies working in the treatment market are Glaukos Corporation, iVeena Delivery Systems, Ocular Therapeutix, Inc., and others, are developing therapies for the Keratoconus treatment
*
Emerging Keratoconus therapies in the different phases of clinical trials are- Riboflavin 5'-Phosphate, IVMED-80, Dextenza, and others are expected to have a significant impact on the Keratoconus market in the coming years.
Keratoconus Overview
Keratoconus is a progressive eye disease in which the normally round, dome-shaped cornea thins and begins to bulge into a cone-like shape. This cone shape deflects light as it enters the eye, causing distorted vision.
Get a Free Sample PDF Report to know more about Keratoconus Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/keratoconus-pipeline-insight [https://www.delveinsight.com/report-store/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging Keratoconus Drugs Under Different Phases of Clinical Development Include:
*
Riboflavin 5'-Phosphate: Glaukos Corporation
*
IVMED-80: iVeena Delivery Systems
*
Dextenza: Ocular Therapeutix, Inc.
Keratoconus Route of Administration
Keratoconus pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
*
Oral
*
Parenteral
*
Intravenous
*
Subcutaneous
*
Topical
Keratoconus Molecule Type
Keratoconus Products have been categorized under various Molecule types, such as
*
Monoclonal Antibody
*
Peptides
*
Polymer
*
Small molecule
*
Gene therapy
Keratoconus Pipeline Therapeutics Assessment
*
Keratoconus Assessment by Product Type
*
Keratoconus By Stage and Product Type
*
Keratoconus Assessment by Route of Administration
*
Keratoconus By Stage and Route of Administration
*
Keratoconus Assessment by Molecule Type
*
Keratoconus by Stage and Molecule Type
DelveInsight's Keratoconus Report covers around 3v+ products under different phases of clinical development like
*
Late-stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I)
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
*
Route of Administration
Further Keratoconus product details are provided in the report. Download the Keratoconus pipeline report to learn more about the emerging Keratoconus therapies [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key companies in the Keratoconus Therapeutics Market include:
Key companies developing therapies for Keratoconus are - CooperVision, Optik Seis, SAFILENS S.R.L, Novartis AG, CIBA VISION, Menicon Co. Ltd, Bausch & Lomb Incorporated, Johnson & Johnson Vision Care Inc, HOYA Vision Care, and others.
Keratoconus Pipeline Analysis:
The Keratoconus pipeline report provides insights into
*
The report provides detailed insights about companies that are developing therapies for the treatment of Keratoconus with aggregate therapies developed by each company for the same.
*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Keratoconus Treatment.
*
Keratoconus key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
Keratoconus Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Keratoconus market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Keratoconus drugs and therapies [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Keratoconus Pipeline Market Strengths
*
Environmental factors contribute to the wide variation in prevalence. Geographical locations with plenty of sunshine and hot weather have a higher prevalence than locations with colder climates and less sunlight
Keratoconus Pipeline Market Opportunities
*
There is limited approved therapy for Keratoconus, which opens up a huge platform of new therapies to boon the market.
Scope of Keratoconus Pipeline Drug Insight
*
Coverage: Global
*
Key Keratoconus Companies: Glaukos Corporation, iVeena Delivery Systems, Ocular Therapeutix, Inc., and others
*
Key Keratoconus Therapies: Riboflavin 5'-Phosphate, IVMED-80, Dextenza, and others
*
Keratoconus Therapeutic Assessment: Keratoconus current marketed and Keratoconus emerging therapies
*
Keratoconus Market Dynamics: Keratoconus market drivers and Keratoconus market barriers
Request for Sample PDF Report for Keratoconus Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Keratoconus Report Introduction
2. Keratoconus Executive Summary
3. Keratoconus Overview
4. Keratoconus- Analytical Perspective In-depth Commercial Assessment
5. Keratoconus Pipeline Therapeutics
6. Keratoconus Late Stage Products (Phase II/III)
7. Keratoconus Mid Stage Products (Phase II)
8. Keratoconus Early Stage Products (Phase I)
9. Keratoconus Preclinical Stage Products
10. Keratoconus Therapeutics Assessment
11. Keratoconus Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Keratoconus Key Companies
14. Keratoconus Key Products
15. Keratoconus Unmet Needs
16 . Keratoconus Market Drivers and Barriers
17. Keratoconus Future Perspectives and Conclusion
18. Keratoconus Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=keratoconus-pipeline-update-2024-fda-approvals-therapeutic-advancements-clinical-trials-by-delveinsight-coopervision-optik-seis-safilens-srl-novartis-ciba-vision-menicon-bausch-lomb]
Phone: +14699457679
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Keratoconus Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, Clinical Trials by DelveInsight | CooperVision, Optik Seis, SAFILENS S.R.L, Novartis, CIBA VISION, Menicon, Bausch & Lomb here
News-ID: 3571051 • Views: …
More Releases from ABNewswire
New Stratalithic Initiative Challenges Entrepreneurship's Biggest Assumption: St …
Image: https://www.abnewswire.com/upload/2026/07/b464fa93d0222a9c1877cb779d9fd197.jpg
ATLANTA, GA - July 13, 2026 - Entrepreneurs are routinely encouraged to believe in themselves, follow their passion, and take the leap.
But what if that advice starts in the wrong place?
Stratalithic, a developer of practical diagnostic systems that examine how people think, work, and make decisions, is introducing a different perspective: entrepreneurship should begin with investigation, not inspiration.
Instead of asking aspiring business owners to immediately build websites, develop products,…
Interview with Abdul Mohammad: The Architect Behind Workforce Transformation
In this exclusive conversation, we speak with Abdul J. Mohammad, a Senior Solution Consultant and Integration Technical Architect with more than 20 years of IT experience and 17 years specializing in workforce management platforms. From leading union-compliant implementations to crafting enterprise-wide integrations that drive automation, Abdul shares insights into his journey, technical mindset, and the future of workforce systems.
Q: Abdul, your resume reflects a rich and varied career. What first…
NotesnChat Releases Application Combining Task Management, Notes, and Secure Com …
The integrated platform provides encrypted messaging, voice and video calling, document scanning, and task organization across iOS, Android, and desktop environments.
Image: https://www.abnewswire.com/upload/2026/07/f8e0be7d01940b728914fdfae7bd98a1.jpg
Software developer RogueBRED Inc. has announced the release of NotesnChat, an application designed to consolidate personal organization, document management, and daily communication into a single workspace. Available across iOS, Android, and desktop platforms, the application reduces the need for users to switch between disparate software programs by combining multiple…
Bahamian Ambassador Tony Joudi Chronicles a Journey from Lebanon to Internationa …
A compelling memoir traces one man's path from childhood in Tyre, Lebanon, through engineering, international business, and diplomatic service across multiple continents.
MARIETTA, GA - Bahamian Ambassador Tony Joudi shares the remarkable journey that carried him from his early years in Tyre, Lebanon, to the world of international diplomacy in His Excellency: The Diplomat from Humble Beginnings in Beirut, Lebanon to the Halls of Diplomacy [https://www.amazon.com/His-Excellency-Diplomat-beginnings-Diplomacy/dp/1968750118]. Spanning decades and multiple continents,…
More Releases for Keratoconus
Valley Optometry Eyecare Center Brings Advanced Keratoconus Treatment to Reseda …
Image: https://www.globalnewslines.com/uploads/2025/09/1758898268.jpg
Valley Optometry Eyecare Center stands as a cornerstone of comprehensive eye care throughout the Greater Los Angeles region. The practice has earned recognition for combining traditional optometric wisdom with modern diagnostic capabilities. Patients from across the San Fernando Valley have come to depend on this facility for everything from basic vision screenings to complex medical interventions that preserve sight.
Keratoconus presents unique challenges that can leave patients feeling hopeless about…
Valley Optometry Eyecare Broadens Awareness Around Reseda Keratoconus Treatment …
Image: https://www.globalnewslines.com/uploads/2025/08/1754401929.jpg
Valley Optometry Eyecare remains a steady presence in the Los Angeles eye care landscape, recognised for its careful, technology-driven approach to diagnosis and long-term treatment. Operating at the intersection of clinical precision and patient accessibility, the centre continues to address lesser-known but increasingly prevalent conditions affecting local vision health.
Among these concerns, keratoconus stands out for its complexity and the subtlety of its onset. Affecting the shape and strength of…
Valley Optometry Eyecare Provides Breakthrough Keratoconus Therapy
Image: https://www.globalnewslines.com/uploads/2025/05/1748342525.jpg
Valley Optometry Eyecare stands at the forefront of advanced eye care for Southern California residents. The practice operates from its central location with modern equipment and highly trained staff ready to tackle complex vision problems. Eye health specialists at this established center work tirelessly to address conditions many patients fear might permanently affect their sight. Valley Optometry Eyecare has earned trust within the community through consistent results and attention…
Keratoconus Treatment Market Size, Share, Trends, Growth and Competitive Analysi …
"Keratoconus Treatment Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. A detailed market research study of this report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as…
Keratoconus Market Size, Share, Trends And Forecast To 2034
How big is the keratoconus market?
The keratoconus market reached a value of US$ 202.1 Million in 2023 and expected to reach US$ 275.0 Million by 2034, exhibiting a growth rate (CAGR) of 2.84% during 2024-2034.
The report offers a comprehensive analysis of the keratoconus market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in…
Keratoconus Market Size, Growth, Research Report & Trends 2023-2033
Keratoconus Market Report Overview:
Report Attribute Details
Base Year …
